June 18, 2008 - TRACON Pharmaceuticals Doses the First Patient in a Phase 1 Clinical Trial with Oral TRC102, an Inhibitor of Chemotherapy Resistance, in Combination with Alimta®
	June 09, 2008 – Asphelia Announces Initiation of an Independent TSO Trial for Multiple Sclerosis
	April 17, 2008 – New panel of global opinion leaders advises CorMedix on treatments for iron-related diseases
	April 17, 2008 – Afferix to help CorMedix devise diagnostic biomarker test
	March 17, 2008 – Ventrus Biosciences and Sam Amer & Company Sign Exclusive License Agreement to Develop Novel Topical Treatment for Hemorrhoids
	January 28, 2008 – Study Shows Coronado Biosciences’ Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models